Zhuhai Rundu Pharmaceutical Co Ltd Class A (002923) — Tangible Net Worth Ratio
Zhuhai Rundu Pharmaceutical Co Ltd Class A (002923) has a Tangible Net Worth Ratio of 94.0% as of September 2025. This metric is calculated by deducting intangible assets (CN¥63.25 Million) from net assets (CN¥1.05 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Zhuhai Rundu Pharmaceutical Co Ltd Class (002923) net assets for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Zhuhai Rundu Pharmaceutical Co Ltd Class A Tangible Net Worth Ratio (2011–2024)
This chart shows how Zhuhai Rundu Pharmaceutical Co Ltd Class A's Tangible Net Worth Ratio has changed across 14 annual periods from 2011 to 2024. As of September 2025, the ratio stands at 94.0%, reflecting net assets of CN¥1.05 Billion with intangible assets of CN¥63.25 Million CNY. Also explore Zhuhai Rundu Pharmaceutical Co Ltd Class (002923) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for Zhuhai Rundu Pharmaceutical Co Ltd Class A (2011–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Zhuhai Rundu Pharmaceutical Co Ltd Class A from 2011 to 2024, covering 14 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see market cap of Zhuhai Rundu Pharmaceutical Co Ltd Class.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 94.4% | CN¥1.15 Billion | CN¥64.42 Million | CN¥2.19 Billion | ▲ +0.0 pp |
| 2023 | 94.4% | CN¥1.18 Billion | CN¥66.05 Million | CN¥2.23 Billion | ▲ +0.1 pp |
| 2022 | 94.3% | CN¥1.20 Billion | CN¥67.62 Million | CN¥2.29 Billion | ▲ +0.6 pp |
| 2021 | 93.8% | CN¥1.11 Billion | CN¥69.00 Million | CN¥1.91 Billion | ▲ +0.1 pp |
| 2020 | 93.7% | CN¥1.04 Billion | CN¥65.47 Million | CN¥1.51 Billion | ▼ -1.0 pp |
| 2019 | 94.7% | CN¥940.29 Million | CN¥50.11 Million | CN¥1.33 Billion | ▼ -2.7 pp |
| 2018 | 97.4% | CN¥871.29 Million | CN¥22.71 Million | CN¥1.14 Billion | ▲ +2.2 pp |
| 2017 | 95.2% | CN¥488.84 Million | CN¥23.27 Million | CN¥706.00 Million | ▲ +1.2 pp |
| 2016 | 94.0% | CN¥398.19 Million | CN¥23.83 Million | CN¥616.60 Million | ▲ +1.9 pp |
| 2015 | 92.2% | CN¥310.72 Million | CN¥24.38 Million | CN¥499.72 Million | ▲ +1.3 pp |
| 2014 | 90.9% | CN¥273.31 Million | CN¥24.94 Million | CN¥375.41 Million | ▲ +1.7 pp |
| 2013 | 89.2% | CN¥236.29 Million | CN¥25.50 Million | CN¥344.54 Million | ▲ +2.3 pp |
| 2012 | 86.9% | CN¥199.43 Million | CN¥26.06 Million | CN¥294.06 Million | ▲ +3.0 pp |
| 2011 | 83.9% | CN¥165.33 Million | CN¥26.61 Million | CN¥238.62 Million | — |